BANK OF AMERICA CORP /DE/ - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is and the CUSIP is 14161WAB1. A total of 14 filers reported holding CARDLYTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2022$1,152,000
+1239.5%
1,965,000
+2211.8%
0.00%
Q1 2022$86,000
+19.4%
85,000
+30.8%
0.00%
Q4 2021$72,000
-96.9%
65,000
-96.5%
0.00%
Q3 2021$2,341,0001,870,0000.00%
Other shareholders
CARDLYTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
683 Capital Management, LLC 16,025,000$9,775,2500.76%
LINDEN ADVISORS LP 58,112,000$36,491,1400.37%
WOLVERINE ASSET MANAGEMENT LLC 33,928,000$21,104,6880.24%
DeepCurrents Investment Group LLC 5,663,000$3,433,4420.15%
CAPSTONE INVESTMENT ADVISORS, LLC 20,160,000$12,511,2960.06%
GABELLI FUNDS LLC 4,560,000$2,834,0400.02%
Verition Fund Management LLC 1,784$1,107,1500.01%
Citadel Advisors 84,195,000$57,252,6000.01%
GAMCO INVESTORS, INC. ET AL 300,000$186,4500.00%
MORGAN STANLEY 130,000$80,0020.00%
View complete list of CARDLYTICS INC shareholders